Mogling Bio is developing novel pharmacological approaches to rejuvenate old stem cells. When we get old, the organization of the internal structures of blood cell forming stem cells, also called hematopoetic stem cells (HSCs), becomes disordered. This leads to an impaired production of blood and immune cells and can cause leukemia and other blood diseases.

Co-founders:

• Jürgen Reeß
• Yi Zheng
• Hartmut Geiger